LipAD™ - Proprietary Lipid-Assembled Drug Delivery Platforms 


TLC is committed to creating solutions for longstanding challenges in drug development by enabling new therapies with entirely unique properties.

LipAD™ allows the design of medicines at the nanometer scale, improving drug solubility, protecting molecules from degradation, or targeting drug delivery to specific tissues and compartments within a cell, creating drugs that are longer lasting with increased efficacy, and enabling new mechanisms that would otherwise be impractical.

These lipid-based technologies enable straightforward development of new formulations of well-known drugs by improving upon their clinical characteristics.

Improving Solubility

Nano-sized drug carrier to incorporate high content of water insoluble drugs, used to increase the concentration of the drug, thus enabling injectable dosage.

More on Polymeric Micelle